4 assets in Liver Lymphoma

Therapeutic assets addressing Liver Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Acalabrutinib Liver Lymphoma	ECOG-ACRIN Cancer Research Group	P2	CCC (53)
Bendamustine Liver Lymphoma	ECOG-ACRIN Cancer Research Group	P2	CCC (53)
Cytarabine Liver Lymphoma	ECOG-ACRIN Cancer Research Group	P2	CCC (53)
Rituximab Liver Lymphoma	ECOG-ACRIN Cancer Research Group	P2	CCC (53)